CTNNB1 and hematopoietic and lymphoid cell neoplasm: The CTNNB1 variant acts as a somatic reversion of the monogenic defect, giving CTNNB1-mutant cells a proliferative advantage, similar to mechanisms in some hematopoietic cancers.10